Loading...
Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice
Well-designed randomized trials provide the highest level of scientific evidence to guide clinical decision making. In chemoradiotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN), data support the use of three cycles of 100 mg/m(2) cisplatin given every 3 weeks concurr...
Na minha lista:
| Udgivet i: | Front Oncol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6579895/ https://ncbi.nlm.nih.gov/pubmed/31245288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00464 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|